Member Info for CFRPflyer

I see today that another bio tech company (OXB) gets contracts to value of 825M and increases 140 p on today’s trading after its 50/1 consolidation two weeks ago it’s price has risen which was totally conterary to what happened with Rene. Can only keep thinking ‘If Only’...but when?

Can someone explain the maths in current SP of 70.18 today. If you have 31.646 million shares in circulation and sell 22279 you have a 3% share drop as seen today of 3p On this performance as in previous days you only need to sell another 527,000 shares to have a nil value. Any thoughts welcome as like many 90% + losses on this share seems to generate no comment from BOD perhaps it’s another Carillion?

I agree with the comments today that in business you can have the best products but if you do not have any proactive access to media vehicles to promote your company then others will fill the void and their results will be the bench mark in stem cell research with Rene successes being further relegated, ie out of sight out of mind. Yes it would be rewarding to have a 2 minute BBC exposure but if media interest is not generated then we can only congratulate those companies who can manipulate media to increase company awareness. I hope those on the BOD can look out of the Welsh factory windows and appreciate it’s a big world of opportunity if it’s correctly promoted outwardly. What do the marketing directors get paid at Rene?

Looking at the 3 week decline in Rene perhaps we need another consolidation? Been a very long serving supporter but starting to have doubts when other bio’s are showing growth in short term. What’s needed is some aggressive marketing iniatives and get this company repositioned. On aposiitive note it’s sunny in Cambridge.

Having agreed on the consolidation at 100/1 to hopefully regulate the fluctuating SP I see we enter this Monday on a further share fall. Can someone explain how if you only sell 11800 shares as of 10.00 am today out of 31.6 million you have a 4p loss? On that basis you would only need to sell less than 500000 shares to have a share value of next to nothing. On other issues last Friday all pharmaceuticals in 250 index rose 1.7% and given that Reneuron made the RNS announcement at a conference on its good test results ,it puzzles me why we only have negative SP. I’ve read all the recent comments and would welcome any insights why we have this manipulation.

Just read that Rene to have office in Boston MA which is a very positive step. I was recently over there and to see the size of the research facilities such as Norvartis can only position Rene where hopefully they can generate more ongoing interest and investment. It would also be a good location should Rene wish to undertake joint ventures to accelerate product development as the expertise needed is readily available. Overall a very positive indication of intent.

Well my long term investment support of 15 years for Torotrak (TRK) now ends today with administrators, I stuck with this as it was innovative desirable technology but lacked publicity and aggressive marketing so did not excite markets and so ends in failure. So what does the Bio Science sector like Rene need to do to get popular support for long term survival? We supposedly have government interventions in this new field but unless we have bod that want to place new companies where more people have access then these start ups will only ever be marginalised. I have followed the recent correspondence between the major contributors to this message forum on Rene future and still remain a believer that this new science will deliver. I hope the government have a better understanding that Bio Science is the future ,because as of yesterday to state they did not know what effect Brexit has on the main GDP sectors of Automotive,Aerospace and Financial services shows that they talk the talk but don’t follow through on walk the walk. I hope Rene come through or that’s another shirt lost.

Well you support innovation for 15 years and it was in my opinion a leading technology but it had no vision or marketing which is indicative of other past developments within UK manufacturing sector. You cannot in any business spend 15 or more years in R&D making something the best always awaiting the best optimisation while your potential customer base starts to look at other technologies due to frustration. I think the bod will sell the intellectual property rights and we will see an overseas buyer reap the rewards of our lost investments. Why would anyone want to support UK innovation when it you see the outcome like this today. I don’t bet on horses but may do now to get a better return .

On reading the companies latest 2017 annual report and with page 2 having independent analysis stating that sales potential of $3.9 billion could be realised for CTX products by 2026 ,I can only surmise that the current Sp of 2p should increase drastically with phase 111 of CTX development scheduled for early 2018....I like most of the regular contributors on this message board have had long term investments in Rene and wish our commitment is well rewarded in next 2 years having recently seen the low Sp. Even if this sales potential is only realised by 25% the turnover will be $1 billion so who would like to estimate a 2020 Sp.

Thankyou for your regular updates and thoughts on this Rene share. I like you remain optimistic that our invest will come good but still remain baffled by why 8 positive RNS news releases from Feb 2017 drive the SP even lower, it's the only share I have which decreases in value every time positive news is indicated which is contrary to all other shares in similar position. I have to retain believe it will come good so now await late 2018 updates , well what's another year we are a band of brothers who have to fight this negativity through this chat forum.

I sometimes feel that this company could go the way of Torotrak plenty of world leading science that eventually returns nothing to its investors but had plenty of promise. I too follow markets and cannot believe that Rene wins another investment award and the share price drops which seems at odds with every other sector which would probably show sp increasing as confidence builds. What will it take to increase this share price? Or is it that failing to communicate the possible success and potential puts off new large investors as the management are seen to lack long term belief. I believe but where is my reward for going so?

Hello all, Reviewing all the information that is circulating out there about potentials and returns and some being pessimistic that Rene may not come good,I still believe as a very longstanding investor that as this is a new field in medicine that some are expecting immediate returns when in fact this is a slow game and one has to have confidence and belief that all will come good with the specialist team who are pioneering the stem cell research.

Having watched the re-run of A Marr programme on his journey to find treatments for strokes that would assist rehabilitation I was interested to hear of all the other clinical institutes that have alternative therapies and wondered where this positioned Reneuron? In other words are we leading or mid table on pioneering developments as the time it takes to get to a marketing position will some else be leading this field? Any thoughts welcome as to whether I should consider more investment with Rene or just hold for long term result.

Hope the Rene presentation provides an insight into when developments may mature. Reading the questions raised for you to ask could you ask if Rene is considering any open days at there new site so us long term investors can see what we are supporting, just a thought.

If I was marketing RENE I'd be asking for a TV meeting with Andrew Marr as he believes he is pioneering this new treatment and is not probably aware of UK developments. Can anyone step up to use this opportunity to our advantage?

I agree with your comments , if we are going to see progress on SP then key achievements and raising the profile are key elements towards success, the long pauses in news releases tends to let the SP slide so their is little consolidation so if we have positive news more frequently it will encourage more investment and possible interest from the bigger players.

Hello all , Does anyone know if TRK has released any statements on progress with Turner power train .consortium? or when any updates will be released, held stock for a longtime and believe in this product development but would expect more reports back from market if things progressing well. Any thoughts welcome

Hello all first message on Reneuron topic as a long standing share holder since 2008 and looking for confirmation in 2017 that the SP moves upwards shortly. Very good report in Daily mail today on Glasgow University and Reneuron activities which reads very positively so hopefully this may stimulate some interest from larger investors in new year.